Wet Age-Related Macular Degeneration (AMD): Baseline Characteristics as Predictors of Response to Anti-Vascular Endothelial Growth Factor (VEGF) Therapy
نویسندگان
چکیده
Kensington Eye Institute Sherif El-Defrawy, MD Ophthalmologist-in-Chief The opinions expressed in this publication do not necessarily represent those of the Department of Ophthalmology and Vision Sciences, Faculty of Medicine, University of Toronto, the educational sponsor, or the publisher, but rather are those of the author based on the available scientific literature. The author has been required to disclose any potential conflicts of interest relative to the content of this publication. Ophthalmology Scientific Update is made possible by an unrestricted educational grant.
منابع مشابه
Vitreomacular Traction Affects Anti-vascular Endothelial Growth Factor Treatment Outcomes for Exudative Age-related Macular Degeneration.
PURPOSE To evaluate the effect of vitreomacular traction (VMT) on visual acuity outcomes and central retinal thickness (CRT) measurements after intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for treatment of exudative age-related macular degeneration (AMD). METHODS In this retrospective series, the authors evaluate the clinical records and optical coherence tomograph...
متن کاملGenerative mathematical modelling to demonstrate virtual simulations of neovascular age related macular degeneration
PURPOSE To develop a generative mathematical model of wet age-related macular degeneration (AMD) and model the impact of injections of anti-vascular endothelial growth factor to virtual patients with the condition. METHODS We isolated key pathophysiological components of macular degeneration in terms of macular edema development and response to anti-vascular endothelial growth factor (VEGF) a...
متن کاملResistance to antivascular endothelial growth factor treatment in age-related macular degeneration
Age-related macular degeneration (AMD) is the main cause of visual impairment and blindness in people aged over 65 years in developed countries. Vascular endothelial growth factor (VEGF) is a positive regulator of angiogenesis and its proven role in the pathological neovascularization in wet AMD has provided evidence for the use of anti-VEGF agents as potential therapies. In this study, we revi...
متن کاملComparative effectiveness of aflibercept for the treatment of patients with neovascular age-related macular degeneration
Wet age-related macular degeneration (AMD) is the most common reason for vision loss in the United States. Many treatments, such as laser therapy and photodynamic therapies, have been used but their efficacy is limited. Emerging anti-vascular endothelial growth factor (VEGF) therapies are now considered the standard of care. Anti-VEGF agents inhibit angiogenesis in the eye by suppressing abnorm...
متن کاملPegaptanib for the treatment of age-related macular degeneration.
Although neovascular (wet) age-related macular degeneration (AMD) only accounts for 10-20% of all AMD, the majority (about 90%) of severe vision loss associated with AMD is due to this form. Results from recent studies have implied that vascular endothelial growth factor (VEGF), particularly VEGF(165), plays a predominant role in the development of ocular neovascularization and vascular leakage...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2014